Black tea, three cups daily,
does it really help with Lower 24-hour ambulatory blood pressure in adults with normal to high-normal pressure?
research showsThe grade is C with 50 points. In a six-month double-blind trial, black tea lowered 24-hour systolic pressure by 2.0 mmHg and diastolic pressure by 2.1 mmHg versus a flavor- and caffeine-matched control. Blood pressure is a surrogate for cardiovascular events, and no validated clinical-importance threshold was found for this between-group context, so clinical magnitude cannot be classified.
ads claimThe product contained caffeine, but the control received the same amount. The trial establishes a roughly 2-mmHg pressure difference, not prevention of myocardial infarction or stroke.
Useful facts when choosing a product
- Three daily cups supplied 1,493 mg of tea solids, 429 mg of polyphenols, and 96 mg of caffeine, about 32 mg caffeine per cup.
- The control matched flavor and caffeine while omitting tea solids, so caffeine exposure did not differ between groups.
- The circa-760 Classic of Tea records tea as a southern tree, but that historical record is not evidence of modern blood-pressure efficacy.
- Verdict 425 is C with 51 points for heat-treated green-tea extract and cognition, while verdict 939 is C with 40 points for green-tea extract and liver enzymes. Verdict 2021 asks a different question about a black-tea beverage and 24-hour pressure.
What the research actually shows
The trial randomized 111 people but analyzed only the 95 baseline completers, 46 tea and 49 control, as its stated intention-to-treat population. Excluding these 16 people is the one analysis defect counted in the bias assessment. Tea supplied 1,493 mg of tea solids, 429 mg of polyphenols, and 96 mg of caffeine daily. Funding came jointly from Australia’s NHMRC and Unilever R&D, and two authors were affiliated with Unilever R&D. The journal was named Archives of Internal Medicine when published in 2012; the article is now hosted on the JAMA Internal Medicine website.
Why this is classified as C (50)
The primary ambulatory-pressure outcome was positive, but it is a surrogate and no validated threshold classifies the clinical magnitude of the roughly 2-mmHg contrast. One trial that analyzed 95 of 111 randomized participants and had mixed public and industry funding yields C with 50 points.
Counterpoint. A large independent long-term replication using the same beverage and dose, plus cardiovascular-event data, is needed.
Rejudgment record. Cross-check applied — The paper and registry were cross-checked for primary 24-hour pressure status, the 95-person analysis, three-cup dose, caffeine-matched control, and mixed funding
| Endpoint | S | Surrogate marker - laboratory or imaging measures |
| Replication | R1 | Single confirmatory trial |
| Independence | I1 | Mixed funding sources |
| Effect size | EX | The clinical size of the effect could not be judged |
The scoring table and the verdict agree (C).
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| The trial beverage contained 96 mg caffeine across three cups | ? | This is a measured composition fact from the paper, not a graded clinical outcome. |
| Three daily cups of black tea lower 24-hour ambulatory blood pressure | C | The primary result was positive, but this was one surrogate-outcome trial without a validated threshold for clinical magnitude. |
Cross-check — Codex and Claude
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Study 1 | Six-month double-blind caffeine-matched randomized parallel trial | 49 | Joint support from Australia's NHMRC and Unilever R&D; two authors were Unilever employees | Primary 24-hour ambulatory systolic and diastolic pressure | At six months, systolic -2.0 mmHg (95% CI -4.0 to -0.0, P=0.05) and diastolic -2.1 (-3.5 to -0.7, P=0.003) | Direct positive evidence, but one pivotal trial without a validated clinical-magnitude threshold |
Receipt — 2 References
All 2 cited sources were verified for existence at the original page (as of 2026-08-03).
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-03 · Corrections: none
Cite this verdict
[Chamgap] Black tea, three cups daily x lower 24-hour ambulatory blood pressure — Evidence Grade C·50. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/heart/black-tea-24-hour-ambulatory-blood-pressure/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.